Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN250774 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Kinase insert Domain Receptor (A Type III Receptor tyrosine Kinase) (KDR) (AA 1300-1367), (C-Term), (Native Form) antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human, Hamster
- Host
- Rabbit
- Epitope
- AA 1300-1367, C-Term, Native Form
- Vial size
- 0.1 mL
- Storage
- Store at 4°C. Do not freeze.
- Handling
- Do not freeze.
Submitted references Oral Mucosa Harbors a High Frequency of Endothelial Cells: A Novel Postnatal Cell Source for Angiogenic Regeneration.
Identification of autocrine growth factors secreted by CHO cells for applications in single-cell cloning media.
Rosuvastatin improves vascular function of arteriovenous fistula in a diabetic rat model.
Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3.
A novel snake venom vascular endothelial growth factor (VEGF) predominantly induces vascular permeability through preferential signaling via VEGF receptor-1.
Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes.
Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells.
Zhou J, Rogers JH, Lee SH, Sun D, Yao H, Mao JJ, Kong KY
Stem cells and development 2017 Jan 15;26(2):91-101
Stem cells and development 2017 Jan 15;26(2):91-101
Identification of autocrine growth factors secreted by CHO cells for applications in single-cell cloning media.
Lim UM, Yap MG, Lim YP, Goh LT, Ng SK
Journal of proteome research 2013 Jul 5;12(7):3496-510
Journal of proteome research 2013 Jul 5;12(7):3496-510
Rosuvastatin improves vascular function of arteriovenous fistula in a diabetic rat model.
Roan JN, Fang SY, Chang SW, Hsu CH, Huang CC, Chiou MH, Tsai YC, Lam CF
Journal of vascular surgery 2012 Nov;56(5):1381-9.e1
Journal of vascular surgery 2012 Nov;56(5):1381-9.e1
Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3.
Hu-Lowe DD, Zou HY, Grazzini ML, Hallin ME, Wickman GR, Amundson K, Chen JH, Rewolinski DA, Yamazaki S, Wu EY, McTigue MA, Murray BW, Kania RS, O'Connor P, Shalinsky DR, Bender SL
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Nov 15;14(22):7272-83
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Nov 15;14(22):7272-83
A novel snake venom vascular endothelial growth factor (VEGF) predominantly induces vascular permeability through preferential signaling via VEGF receptor-1.
Takahashi H, Hattori S, Iwamatsu A, Takizawa H, Shibuya M
The Journal of biological chemistry 2004 Oct 29;279(44):46304-14
The Journal of biological chemistry 2004 Oct 29;279(44):46304-14
Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes.
Gluzman-Poltorak Z, Cohen T, Shibuya M, Neufeld G
The Journal of biological chemistry 2001 Jun 1;276(22):18688-94
The Journal of biological chemistry 2001 Jun 1;276(22):18688-94
Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells.
Rahimi N, Dayanir V, Lashkari K
The Journal of biological chemistry 2000 Jun 2;275(22):16986-92
The Journal of biological chemistry 2000 Jun 2;275(22):16986-92
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB